This graph shows the total turnover excluding taxes of the French medicines market from 2010 to 2018, in manufacturer price excluding taxes and in million euros. In 2018, the total turnover of the French medicines market was approximately 55 billion euros.
Total turnover of the French medicines market from 2010 to 2018, in manufacturer price excluding taxes* (in million euros)
Loading statistic...
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Distribution of the turnover of the pharmaceuticals market in France 2017, by segment
- Premium Statistic Distribution of pharmaceutical products expenditure in Italy 2022, by channel
- Premium Statistic Production price of pharmaceuticals on domestic market in Italy 2005-2021
- Premium Statistic Sales revenue distribution of JW Pharmaceutical South Korea 2022, by channel
- Basic Statistic Canadian drug market sales contribution of patented drugs 1990-2022
- Premium Statistic Revenue of phytopharmaceuticals in Germany in 2022, by sales channel
- Premium Statistic Share of regional pharmaceutical expenditure in Italy 2021, by region and distributor
- Premium Statistic Pharmaceutical production value in Mexico 2021, by segment
- Premium Statistic Pharmaceutical production volume in Mexico 2021, by segment
- Premium Statistic Pharmaceutical sales value in Mexico 2021, by segment
About the region
10
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Basic Statistic Breakdown of the workforce of Sanofi 2018, by geographical location
- Basic Statistic Sanofi's workforce in 2018, by segment
- Basic Statistic Companies in the manufacture of pharmaceutical products in France 2011-2022
- Basic Statistic Total R&D expenditure of French pharmaceutical companies 2017
- Premium Statistic Social security: financing of healthcare and medical goods in France 2018, by post
- Basic Statistic Turnover of medicines distributed in hospitals in France 2010-2018
- Premium Statistic Current health expenditure in France 2018, by type of expenditure
- Premium Statistic Belief that the toxicity of vaccines is covered up by the government in France 2018
- Premium Statistic Health: distribution of healthcare consumption and medical goods in France 2018
Selected statistics
7
- Premium Statistic Annual revenue of Sinopharm 2010-2022
- Premium Statistic Number of employees at Sinopharm 2011-2022
- Premium Statistic Pfizer's ad spending 2006-2023
- Premium Statistic Revenue of Sinopharm 2011-2022, by category
- Premium Statistic Annual revenue of Shanghai Pharmaceuticals 2011-2022
- Basic Statistic M&A capacities - changes for the global pharma industry 2008-2015
- Premium Statistic Enterprise and brand value of Shoppers Drug Mart in 2012
Other regions
10
- Premium Statistic High-tech industry revenue in China by sector 2021
- Premium Statistic Number of total approvals by top pharmaceutical companies 2017
- Premium Statistic Global in vitro diagnostics market share by top medtech companies 2017 and 2024
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Premium Statistic Major biologics to lose patent protection 2015-2020 by EU5 and U.S. revenue
- Premium Statistic Colombia: top drug store chains in 2017. by size
- Premium Statistic Physicians that received opioid-manufacturer payments in New York 2013-2015
- Premium Statistic Latin America: per capita sales of OTC medicines 2017, by country
- Basic Statistic Canadian vs US price difference of select oral solid opioids 2017
- Premium Statistic Brazil: Hypera Pharma's ad spending 2016-2018
Related statistics
10
- Basic Statistic Average cost of hospital per day by country 2015
- Basic Statistic Number of opioid and naloxone prescriptions in the U.S. 2018, by prescriber specialty
- Premium Statistic Retail clinics market size in the U.S. forecast for 2024-2029
- Premium Statistic Value of U.S. medical malpractice payments 1991-2015
- Premium Statistic U.S. medical malpractice payments as a percent of overall health care costs 1991-2015
- Premium Statistic Number of medical malpractice payments 1991-2015
- Premium Statistic Households: financing healthcare and medical goods in France 2010-2015
- Basic Statistic Breakdown of employees of drug companies by age France 2014
- Premium Statistic Health professions: monthly salaries in France 2015
- Premium Statistic U.S. market share of retail clinic top operators
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's expenditure on research and development 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co total assets 2009-2023
- Merck & Co cash dividends declared 2006-2023
- Sanofi's total assets 2007-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Medicare - number of skilled nursing facilities in the U.S. 1967-2021
- AstraZeneca's expenditure on research and development 2006-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Sales of Johnson & Johnson worldwide 2011-2023, by segment
LEEM. (September 16, 2019). Total turnover of the French medicines market from 2010 to 2018, in manufacturer price excluding taxes* (in million euros) [Graph]. In Statista. Retrieved May 02, 2024, from https://www.statista.com/statistics/1073523/figure-d-business-total-market-french-drugs/
LEEM. "Total turnover of the French medicines market from 2010 to 2018, in manufacturer price excluding taxes* (in million euros)." Chart. September 16, 2019. Statista. Accessed May 02, 2024. https://www.statista.com/statistics/1073523/figure-d-business-total-market-french-drugs/
LEEM. (2019). Total turnover of the French medicines market from 2010 to 2018, in manufacturer price excluding taxes* (in million euros). Statista. Statista Inc.. Accessed: May 02, 2024. https://www.statista.com/statistics/1073523/figure-d-business-total-market-french-drugs/
LEEM. "Total Turnover of The French Medicines Market from 2010 to 2018, in Manufacturer Price excluding Taxes* (in Million Euros)." Statista, Statista Inc., 16 Sep 2019, https://www.statista.com/statistics/1073523/figure-d-business-total-market-french-drugs/
LEEM, Total turnover of the French medicines market from 2010 to 2018, in manufacturer price excluding taxes* (in million euros) Statista, https://www.statista.com/statistics/1073523/figure-d-business-total-market-french-drugs/ (last visited May 02, 2024)
Total turnover of the French medicines market from 2010 to 2018, in manufacturer price excluding taxes* (in million euros) [Graph], LEEM, September 16, 2019. [Online]. Available: https://www.statista.com/statistics/1073523/figure-d-business-total-market-french-drugs/